Proper use of T-lymphocyte immunity and interferon during KOVID-19 infection
- VernacularTitle:Т-Лимфоцитын дархлаа ба интерфероны индукторын КОВИД-19 халдварын үеийн зохистой хэрэглээ
- Author:
Uynden S
1
;
Erdenetsogt D
2
;
Gerelmaa D
3
;
Unursaikhan S
4
Author Information
1. Gegeemed toxicology hospital
2. Mongolian National Council of Scientists
3. Intermed Hospital
4. National Center for Public health
- Publication Type:Review
- Keywords:
SARS-COV-2;
POSTКОВИД-19 syndrome;
innate T-lymphocyte immunity;
interferon inducer;
endogenous interferon
- From:Mongolian Medical Sciences
2021;198(4):78-87
- CountryMongolia
- Language:Mongolian
-
Abstract:
The risk of reinfection of the across mutation SARS-CoV-2 set the task of medicine to look for new
ways to solve. One of these areas is the strengthening of innate T-lymphocyte immunity. Research
on the use of an interferon inducer by stimulating innate T-lymphocyte immunity in order to innate
prevent КОВИД-19 and its mutant forms and during the rehabilitation period after an illness, they
give good scientific results and one of the future promising directions of prevention and treatment of
КОВИД-19. Researchers have warned that the side effects of SARS-CoV-2 drugs include respiratory
failure, decreased blood albumin levels, decreased red blood cells and platelets, anemia and
coagulation disorders, jaundice, and liver damage. Adverse drug reactions include drug intoxication
and adverse reactions, as well as immune reactions. For these reasons, the need to seek new
methods of treatment and prevention and drugs has become one of the most pressing issues in
modern medicine.
- Full text:2021-198(4)-78-87.pdf
